Update on Indications, Interactions and Complications in the Use of Pharmaceuticals

Course

In Departs Honolulu (USA)

£ 555.55 VAT exempt

*Indicative price

Original amount in USD:

$ 695

Description

  • Type

    Course

  • Location

    Departs honolulu (USA)

  • Duration

    7 Days

Suitable for: Pharmacists, Primary Care Physicians, Nurses, NPs, PAs

Facilities

Location

Start date

Departs Honolulu (USA)
See map

Start date

On request

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

Course programme

Course review:

After attending the following session individuals should be able to:

1. Outline strategies for assessing and counseling patients on the use of OTC products.
2. Describe patients attitude about monitoring and diagnostics for self-care.
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
4. Describe the mechanism of action and indications for newly approved drugs.
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.

********************************************************************************

Patient’s Role in Self-Care: Working with Their Health Care Providers
1. Outline strategies for assessing and counseling patients on the use of OTC products.
Monitoring and Diagnostic Devices for Self-Care
2. Describe patients attitude about monitoring and diagnostics for self-care.
FDA and Regulatory Update on Pharmaceuticals
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance
New Product Approvals for 2011
4. Describe the mechanism of action and indications for newly approved drugs.
Medication Safety and Medication Errors in the Medication Use Process
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
Minimizing Medication Errors and Liability Through Technology
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
Developing Collaborative Care Models
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.

Conference Sessions generally take place during the days at sea (as cruise itinerary allows) to avoid conflicts with Ports of Call or evening entertainment.

Additional information

Credits/Points: 695

Update on Indications, Interactions and Complications in the Use of Pharmaceuticals

£ 555.55 VAT exempt

*Indicative price

Original amount in USD:

$ 695